|
시장보고서
상품코드
2121012
섬유성 생존 골 기질 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 소스별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Fiber Viable Bone Matrix Market Size, Share, and Growth Analysis, By Product Type (Putty, Strip), By Application (Spinal Fusion, Trauma Surgery), By Source, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 섬유성 생존 골 기질(FVBM) 시장 규모는 2024년에 18억 4,000만 달러로 평가되며, 2025년 19억 9,000만 달러에서 2033년까지 38억 달러로 확대할 전망이며, 예측 기간(2026-2033년)에 CAGR 8.4%로 성장할 것으로 전망되고 있습니다.
전 세계 섬유성 생존 골 기질(FVBM) 시장은 정형외과 및 치과 수술에서 효과적인 이식재 대체물에 대한 수요가 증가함에 따라 눈에 띄는 성장을 달성하고 있습니다. 천연 콜라겐 섬유와 탈회골기질를 결합한 이 복합 스캐폴드는 생체 뼈의 구조와 매우 유사하여, 골 형성을 촉진하는 동시에 이식편 거부 반응을 최소화합니다. 고령화에 따라 만성 근골격계 질환의 유병률이 증가하는 가운데, 외과의사들은 FVBM의 신속한 하중 내성 및 재활 조기화, 입원 기간 단축과 같은 환자 예후 개선을 이유로 FVBM을 점점 더 선호하고 있습니다. 또한 유리한 의료 정책과 제품에 대한 규제 승인으로 시장 접근성이 향상되고 있습니다. 바이오 제조에 대한 투자와 성장인자 전달에 관한 전략적 제휴도 시장 확대를 더욱 지원하고 있으며, FVBM은 정형외과 및 치과 분야의 발전에서 매우 중요한 솔루션으로서 입지를 확고히 다져가고 있습니다.
전 세계 섬유성 생존 골 기질 시장의 성장 요인
근골격계 질환의 발생률 증가와 인구 고령화가 맞물려, 혁신적인 골 재생 솔루션에 대한 지속적인 수요가 발생하고 있습니다. 임상의들이 천연 조직과 매끄럽게 융합되는 바이오소재를 점점 더 요구함에 따라 섬유성 생존 골 기질은 외과적 목표에 부합하는 기계적 강도와 생체활성 특성을 겸비한 유망한 대안으로 부상하고 있습니다. 이러한 임상 현장의 지지 확대는 병원 및 전문 의료 센터의 치료 프로토콜에 해당 소재의 채택을 촉진할 뿐만 아니라, 연구 제휴 촉진 및 유통 네트워크 확대로 이어져 궁극적으로 시장 성장을 지원하고 있습니다. 또한 양호한 환자 예후를 보여주는 증거가 축적됨에 따라 이 기술의 임상적 우월성이 더욱 입증되어, 정형외과 전문가 및 의료비 지급 기관 사이에서 더 널리 수용되고 있습니다.
전 세계 섬유성 생존 골 기질 시장의 제약 요인
섬유 함유 생체 골 기질의 제조에는 섬유의 정밀한 배열, 멸균, 철저한 품질관리 등 복잡한 공정이 수반되므로 생산 비용이 높아집니다. 이러한 비용 증가는 의료 제공자에게 전가되어 가격 책정에 영향을 미치며, 소규모 진료소나 개발도상국 시장에서 제품의 접근성을 저해하고 있습니다. 그 결과, 비용을 중시하는 의료 기관은 더 저렴한 바이오소재 대체품을 선택할 가능성이 있으며, 이는 전반적인 보급률을 저해할 우려가 있습니다. 또한 이러한 재정적 제약은 잠재적 투자자들을 멀어지게 할 가능성이 있으며, 신제품 개발을 지연시키고 시장 성장을 저해할 우려가 있습니다. 이러한 경제적 과제는 임상 현장에서의 광범위한 도입을 제한하고, 치료 선택지에서의 귀중한 진전을 늦추는 요인이 됩니다.
전 세계 섬유성 생존 골 기질 시장의 동향
전 세계 섬유성 생체 골 기질 시장은 난치성 골절 및 재건 수술에 대한 이 첨단 이식 솔루션이 정형외과 분야에서 점점 더 많은 지지를 얻고 있는 것을 배경으로 견고한 상승 추세를 보이고 있습니다. 외과의사들은 이 제품의 뛰어난 생체 적합성과 기증 부위에 미치는 부담이 최소화되었다는 점을 높이 평가하고 있으며, 이는 최소 침습 수술의 증가라는 추세와 완벽하게 부합합니다. 병원들은 이러한 혁신적인 매트릭스를 도입하기 위해 조달 전략을 재검토하고 있으며, 의료기기 유통업체들도 취급 품목을 확대하여 이를 포함시키고 있습니다. 이러한 추세는 임상적 근거의 축적, 더 빠른 회복을 원하는 환자들의 수요 증가, 그리고 재생의학적 정형외과 치료를 지원하는 성과 연계형 보상 모델로의 전환에 의해 지원되고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 섬유성 생존 골 기질 시장 규모 : 제품 유형별
세계의 섬유성 생존 골 기질 시장 규모 : 용도별
세계의 섬유성 생존 골 기질 시장 규모 : 소스별
세계의 섬유성 생존 골 기질 시장 규모 : 최종사용자별
세계의 섬유성 생존 골 기질 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.09.08Global Fiber Viable Bone Matrix Market size was valued at USD 1.84 Billion in 2024 and is poised to grow from USD 1.99 Billion in 2025 to USD 3.8 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).
The global fiber viable bone matrix (FVBM) market is experiencing significant growth, driven by a rising demand for effective graft alternatives in orthopedic and dental procedures. This composite scaffold, which combines natural collagen fibers with demineralized bone matrix, closely resembles native bone architecture, promoting osteogenesis while minimizing graft rejection. As the incidence of chronic musculoskeletal disorders increases among aging populations, surgeons increasingly favor FVBM for its rapid load-bearing capacity and improved patient outcomes, including faster rehabilitation and reduced hospital stays. Additionally, favorable healthcare policies and product regulatory approvals enhance market accessibility. Investments in bio-manufacturing and strategic collaborations in growth-factor delivery further fuel market expansion, positioning FVBM as a pivotal solution in orthopedic and dental advancements.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fiber Viable Bone Matrix market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fiber Viable Bone Matrix Market Segments Analysis
Global fiber viable bone matrix market is segmented by product type, application, source, end user and region. Based on product type, the market is segmented into putty, strip and moldable matrix. Based on application, the market is segmented into spinal fusion, trauma surgery, orthopedic reconstruction and foot & ankle surgery. Based on source, the market is segmented into allograft and demineralized bone matrix. Based on end user, the market is segmented into hospitals, orthopedic clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Fiber Viable Bone Matrix Market
The rising incidence of musculoskeletal disorders, coupled with an aging demographic, drives a persistent demand for innovative bone repair solutions. As clinicians increasingly seek biomaterials that seamlessly integrate with natural tissue, fiber viable bone matrix emerges as a favorable option, offering both mechanical strength and bioactive properties that align with surgical goals. This growing clinical preference not only enhances the adoption of such materials in treatment protocols within hospitals and specialty centers but also fosters research partnerships and expands distribution networks, thereby bolstering market growth. Furthermore, accumulating evidence of positive patient outcomes further reinforces the clinical advantages of this technology, leading to broader acceptance among orthopedic professionals and healthcare payers.
Restraints in the Global Fiber Viable Bone Matrix Market
The complex processes involved in manufacturing fiber viable bone matrix, such as precise fiber alignment, sterilization, and thorough quality control, lead to higher production costs. These increased expenses are then passed on to healthcare providers, affecting pricing approaches and making the product less affordable for smaller clinics or developing markets. As a result, cost-sensitive institutions may opt for cheaper biomaterial alternatives, which can hinder overall adoption rates. Additionally, these financial limitations may deter potential investors, slowing the development of new products and stifling market growth. This economic challenge restricts broad clinical implementation and delays valuable advancements in treatment options.
Market Trends of the Global Fiber Viable Bone Matrix Market
The Global Fiber Viable Bone Matrix market is witnessing a robust upward trajectory, fueled by the orthopedic community's increasing endorsement of this advanced grafting solution for challenging fractures and reconstruction. Surgeons appreciate its enhanced biological integration and minimal donor-site morbidity, which aligns seamlessly with the rising trend of minimally invasive surgeries. Hospitals are revising procurement strategies to incorporate these innovative matrices, while medical device distributors are broadening their offerings to include them. This trend is underpinned by an expanding body of clinical evidence, heightened patient demand for quicker recovery times, and a shift towards outcomes-based reimbursement models that favor regenerative orthopedic treatments.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Fiber Viable Bone Matrix Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Putty
- Strip
- Moldable Matrix
Global Fiber Viable Bone Matrix Market Size by Application & CAGR (2026-2033)
- Market Overview
- Spinal Fusion
- Trauma Surgery
- Orthopedic Reconstruction
- Foot & Ankle Surgery
Global Fiber Viable Bone Matrix Market Size by Source & CAGR (2026-2033)
- Market Overview
- Allograft
- Demineralized Bone Matrix
Global Fiber Viable Bone Matrix Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
Global Fiber Viable Bone Matrix Market Size & CAGR (2026-2033)
- North America (Product Type, Application, Source, End User)
- US
- Canada
- Europe (Product Type, Application, Source, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, Source, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Globus Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthofix Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LifeNet Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MTF Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AlloSource
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RTI Surgical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SeaSpine Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xtant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bone Biologics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arthrex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith+Nephew plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Exactech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioventus Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Osiris Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Surgenex LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
